A
Alcista
Alcista · 25%JYNT
$10.79
Precio del escenario
$7.370
-0.137 (-1.86%)Al cierre
Loading chart…
- Máximo
- 7.630
- Apertura
- 7.510
- Precio medio ponderado por volumen
- 7.46
- Volumen
- 59.83K
- Capitalización
- 204.84M
- Mínimo
- 7.370
- Importe
- 446.12K
- EV/EBITDA, TTM
- 22.84
The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
Análisis de IA of Joint Corp (JYNT)
ComprarJoint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.
Recomendaciones de analistas (3)
+53.73% de potencial alcista
Comprar
3 Comprar
0 Mantener
0 Vender
Actual: 7.37
Mínimo
9.00
Promedio
11.33
Máximo
14.00
Roth Capital
Comprar
$12
2026-03-13
Roth Capital
2026-03-13
Precio objetivo
$12
Comprar
B. Riley
Neutral
$9
2025-11-07
B. Riley
2025-11-07
Precio objetivo
$9
Neutral
Lake Street
Comprar
$11
2025-11-07
Lake Street
2025-11-07
Precio objetivo
$11
Comprar
Roth Capital
Comprar
$14
2025-11-07
Roth Capital
2025-11-07
Precio objetivo
$14
Comprar
Lake Street
Comprar
$16
2025-05-09
Lake Street
2025-05-09
Precio objetivo
$16
Comprar
Métricas de valoración
El PER previsto actual de Joint Corp (JYNT) es 9.47, frente a su media de 5 años de 86.45.
Escenarios de precio de Alphio AI para JYNT
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
9.510-22NewsfilterThe Joint Corp. to Report Q3 Financial Results on November 5, 2026
8.510-06PRnewswireTexas Territory Reacquisition Enhances The Joint's Franchise Growth Strategy
- 8.510-06Newsfilter
The Joint Reacquires Texas Development Rights to Accelerate Franchise Growth
8.507-30PRnewswireThe Joint Corp. Recognized as Top Brand for Multi-Unit Owners
- 8.507-30Newsfilter
The Joint Chiropractic Recognized as Top Brand for Multi-Unit Owners
Preguntas frecuentes sobre JYNT, respondidas por Alphio AI
The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations. It operates in the Healthcare sector (PATENT OWNERS & LESSORS industry).
Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.
3 analysts cover JYNT: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 11.33.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.